0
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
1
the efficacy and cost effectiveness of cognitive behavioural therapy, interpersonal therapy and 0 the effectiveness of maintenance ect for relapse prevention in people with severe and recurring
T4
T3
cognitive behavioural therapy	false	1.2946
T2
T1
st	false	1.3333
relapse	false	0.7576999999999999
effectiveness	false	0.6819999999999999
ect	false	0.6640999999999999
##########END##########
2
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
3
this guideline covers identifying and managing depression in adults aged 18 years and older, in primary and secondary care
T4
T3
T2
secondary care	false	0.837
T1
guideline	false	0.6181
age	false	0.5051
##########END##########
4
mhra advice on valproate: in april 2018, we added warnings that valproate must not be used in pregnancy, and only used in girls and women when there is no alternative and a pregnancy prevention plan is in place
T4
T3
T2
T1
pregnancy	true	1.3333
valproate	true	0.6819999999999999
st	false	1.3333
plan	false	0.7734
place	false	0.5915
iv	false	0.5482
##########END##########
5
nice has also produced a guideline on depression in adults with a chronic physical health problem (nice guideline cg91).
T4
chronic physical health problem	false	0.7096999999999999
T3
T2
T1
guideline	false	0.6181
##########END##########
6
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
7
the update information section has a list of recommendations for which the evidence has not been updated since the original guideline.
T4
T3
update information section	false	1.3333
T2
original guideline	false	1.2263
T1
st	false	1.3333
update	false	1.0
recommendation	false	0.8769
evidence	false	0.7991999999999999
##########END##########
8
this guideline is published alongside 'depression in adults with a chronic physical health problem: recognition and management' (nice clinical guideline 91) which makes recommendations on the identification treatment and management of depression in adults aged 18 years and older who also have a chronic physical health problem.
T4
chronic physical health problem	false	0.7096999999999999
T3
nice clinical guideline	false	0.6939
T2
identification treatment	false	0.9643000000000002
T1
recommendation	false	0.8769
guideline	false	0.6181
age	false	0.5051
##########END##########
9
this guideline makes recommendations on the identification, treatment and management of depression in adults aged 18 years and older, in primary and secondary care
T4
T3
T2
secondary care	false	0.837
T1
recommendation	false	0.8769
identification	false	0.8129
guideline	false	0.6181
age	false	0.5051
##########END##########
10
this guideline covers people whose depression occurs as the primary diagnosis; the relevant nice guidelines should be consulted for depression occurring in the context of other disorders (see our topic page on depression).
T4
T3
relevant nice guidelines	false	1.245
T2
other disorders	true	1.1427
primary diagnosis	false	1.1427
topic page	false	1.1427
T1
context	false	0.9786000000000001
guideline	false	0.6181
##########END##########
11
symptoms should be present for at least 2 weeks and each symptom should be present at sufficient severity for most of every day
T4
T3
T2
sufficient severity	false	1.1886
T1
day	true	0.9623
st	false	1.3333
##########END##########
12
symptoms are considered persistent if they continue despite active monitoring and/or low-intensity intervention, or have been present for a considerable time, typically several months (for a diagnosis of dysthymia, symptoms should be present for at least 2 years .)
T4
T3
T2
considerable time	false	1.1886
low-intensity intervention	false	1.1886
active monitoring	false	0.6098999999999999
T1
st	false	1.3333
diagnosis	false	1.0229
months	false	0.651
##########END##########
13
it should be noted that classificatory systems are agreed conventions that seek to define different severities of depression in order to guide diagnosis and treatment, and their value is determined by how useful they are in practice
T4
T3
T2
classificatory systems	false	0.6980999999999999
T1
diagnosis	false	1.0229
note	false	1.0
term	false	1.0
order	false	0.5977
conventions	false	0.5482
practice	false	0.5482
severities	false	0.5482
##########END##########
14
after careful review of the diagnostic criteria and the evidence, the
T4
T3
T2
careful review	false	0.6980999999999999
diagnostic criteria	false	0.6980999999999999
T1
evidence	false	0.7991999999999999
##########END##########
15
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
16
iv is used in nearly all the evidence reviewed and it provides definitions for atypical symptoms and seasonal depression
T4
T3
T2
atypical symptoms	false	0.6980999999999999
seasonal depression	false	0.6980999999999999
T1
review	true	0.5482
evidence	false	0.7991999999999999
definitions	false	0.5482
iv	false	0.5482
##########END##########
17
in practical terms, clinicians are not expected to switch to dsm-iv but should be aware that the threshold for mild depression is higher than icd-10 (five symptoms instead of four) and that degree of functional impairment should be routinely assessed before making a diagnosis
T4
T3
T2
mild depression	false	0.8528000000000001
practical terms	false	0.6980999999999999
T1
dsm-iv	true	0.5482
icd-10	true	0.5482
st	false	1.3333
diagnosis	false	1.0229
degree	false	0.852
ect	false	0.6640999999999999
clinicians	false	0.5482
iv	false	0.5482
threshold	false	0.5482
##########END##########
18
therefore it is also important to consider both personal past history and family history of depression when undertaking a diagnostic assessment (see appendix for further details).
T4
T3
personal past history	false	0.7651
T2
diagnostic assessment	false	0.6980999999999999
family history	false	0.6980999999999999
T1
appendix	false	0.5482
details	false	0.5482
##########END##########
19
where possible, the key goal of an intervention should be complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse.
T4
T3
T2
complete relief	false	1.2263
key goal	false	1.2263
T1
functioning	true	1.0
likelihood	false	1.1046
relapse	false	0.7576999999999999
intervention	false	0.6759
##########END##########
20
the guideline assumes that prescribers will use a drug's summary of product characteristics (spc) and the 'british national formulary' (bnf) to inform their decisions made with individual patients.
T4
T3
british national formulary	false	1.3333
T2
individual patients	false	1.2263
product characteristics	false	1.2263
T1
spc	true	0.5423
drug	true	0.5234
bnf	false	1.0
form	false	1.0
prescribers	false	1.0
summary	false	1.0
guideline	false	0.6181
##########END##########
21
this guideline recommends some drugs for indications for which they do not have a uk marketing authorisation at the date of publication, if they are already in use in the nhs for that indication, and there is good evidence to support that use
T4
T3
uk marketing authorisation	false	1.6
T2
T1
drug	true	0.5234
indication	false	1.3333
publication	false	1.3333
evidence	false	0.7991999999999999
guideline	false	0.6181
##########END##########
22
uk marketing authorisation for depression or the indication stated at the time of publication.
T4
T3
uk marketing authorisation	false	1.6
T2
T1
indication	false	1.3333
publication	false	1.3333
st	false	1.3333
time	false	0.6736
##########END##########
23
section of this guideline updates recommendations made in 'guidance on the use of electroconvulsive therapy' (nice technology appraisal guidance 59) for the treatment of depression only
T4
nice technology appraisal guidance	false	0.9053
T3
T2
T1
update	false	1.0
recommendation	false	0.8769
guidance	false	0.7817999999999999
ect	false	0.6640999999999999
guideline	false	0.6181
iv	false	0.5482
##########END##########
24
recommendation of this guideline updates recommendations made in 'computerised cognitive behaviour therapy for depression and anxiety' (nice technology appraisal guidance 97) for the treatment of depression only
T4
nice technology appraisal guidance	false	0.9053
computerised cognitive behaviour therapy	false	0.5095
T3
T2
T1
anxiety	true	0.8421000000000001
update	false	1.0
recommendation	false	0.8769
guideline	false	0.6181
##########END##########
25
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
26
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
27
principles for assessment
T4
T3
T2
T1
assessment	false	0.6628000000000001
##########END##########
28
when assessing a person who may have depression, conduct a comprehensive assessment that does not rely simply on a symptom count
T4
T3
T2
T1
assessment	false	0.6628000000000001
iv	false	0.5482
##########END##########
29
all interventions for depression should be delivered by competent practitioners
T4
T3
T2
competent practitioner	false	1.2263
T1
intervention	false	0.6759
iv	false	0.5482
##########END##########
30
psychological and psychosocial interventions should be based on the relevant treatment manual(s), which should guide the structure and duration of the intervention
T4
T3
relevant treatment manual(s)	false	1.5562
T2
T1
st	false	1.3333
intervention	false	0.6759
##########END##########
31
practitioners should consider using competence frameworks developed from the relevant treatment manual(s) and for all interventions should: receive regular high-quality supervision use routine outcome measures and ensure that the person with depression is involved in reviewing the efficacy of the treatment engage in monitoring and evaluation of treatment adherence and practitioner competence – for example, by using video and audio tapes, and external audit and scrutiny where appropriate.
T4
T3
relevant treatment manual(s)	false	1.5562
T2
outcome measure	false	0.7273
T1
review	true	0.5482
work	false	1.0
competence	false	0.9177999999999998
intervention	false	0.6759
ensure	false	0.6597
practitioners	false	0.5533
iv	false	0.5482
age	false	0.5051
##########END##########
32
be alert to possible depression (particularly in people with a past history of depression or a chronic physical health problem with associated functional impairment) and consider asking people who may have depression two questions, specifically:
T4
chronic physical health problem	false	0.7096999999999999
T3
T2
T1
st	false	1.3333
part	false	0.6348
##########END##########
33
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
34
last updated april 2018 consider offering one or more of the following interventions, guided by the person's preference: individual guided self-help based on the principles of cognitive behavioural therapy (cbt) computerised cognitive behavioural therapy (ccbt) a structured group physical activity programme.
T4
group physical activity programme	false	0.5826
T3
cognitive behavioural therapy	false	1.2946
T2
T1
st	false	1.3333
refer	false	1.0
update	false	1.0
self-help	false	0.7616999999999999
intervention	false	0.6759
iv	false	0.5482
##########END##########
35
do not use antidepressants routinely to treat persistent subthreshold depressive symptoms or mild depression because the risk–benefit ratio is poor, but consider them for people with: a past history of moderate or severe depression or initial presentation of subthreshold depressive symptoms that have been present for a long period (typically at least 2 years) or subthreshold depressive symptoms or mild depression that persist(s) after other interventions.
T4
T3
subthreshold depressive symptoms	false	0.6527999999999999
T2
mild depression	false	0.8528000000000001
T1
st	false	1.3333
antidepressants	false	0.7967
period	false	0.7526
intervention	false	0.6759
##########END##########
36
for people with moderate or severe depression, provide a combination of antidepressant medication and a high-intensity psychological intervention (cbt or ipt).
T4
T3
high-intensity psychological intervention	false	1.0919
T2
antidepressant medication	false	0.8141
T1
ipt	false	0.7725000000000001
combination	false	0.6143
##########END##########
37
continuation and relapse prevention
T4
T3
T2
T1
relapse	false	0.7576999999999999
##########END##########
38
psychological interventions for relapse prevention
T4
T3
T2
psychological intervention	false	1.0532
T1
relapse	false	0.7576999999999999
##########END##########
39
people with depression who are considered to be at significant risk of relapse (including those who have relapsed despite antidepressant treatment or who are unable or choose not to
T4
T3
T2
antidepressant treatment	false	1.1678000000000002
significant risk	false	0.7038
T1
relapse	false	0.7576999999999999
##########END##########
40
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
41
last updated april 2018 continue antidepressant treatment) or who have residual symptoms, should be offered one of the following psychological interventions: individual cbt for people who have relapsed despite antidepressant medication and for people with a significant history of depression and residual symptoms despite treatment mindfulness-based cognitive therapy for people who are currently well but have experienced three or more previous episodes of depression.
T4
T3
T2
residual symptoms	false	1.1971
antidepressant treatment	false	1.1678000000000002
psychological intervention	false	1.0532
antidepressant medication	false	0.8141
T1
st	false	1.3333
episode	false	1.0
update	false	1.0
relapse	false	0.7576999999999999
iv	false	0.5482
##########END##########
42
this recommendation (and recommendation in cg91) updates the recommendations on depression only in 'computerised cognitive behaviour therapy for depression and anxiety' (nice technology appraisal guidance 97).
T4
nice technology appraisal guidance	false	0.9053
computerised cognitive behaviour therapy	false	0.5095
T3
T2
T1
anxiety	true	0.8421000000000001
update	false	1.0
recommendation	false	0.8769
##########END##########
43
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
44
note that a comprehensive assessment of depression should not rely simply on a symptom count, but should take into account the degree of functional impairment and/or disability (see section ).
T4
T3
T2
T1
account	true	0.8969999999999999
disability	false	1.2241
note	false	1.0
degree	false	0.852
ect	false	0.6640999999999999
assessment	false	0.6628000000000001
iv	false	0.5482
##########END##########
45
this guideline is published alongside 'depression in adults with a chronic physical health problem: recognition and management' (nice clinical guideline 91), which makes recommendations on the identification, treatment and management of depression in adults aged 18 years and older who also have a chronic physical health problem.
T4
chronic physical health problem	false	0.7096999999999999
T3
nice clinical guideline	false	0.6939
T2
T1
recommendation	false	0.8769
identification	false	0.8129
guideline	false	0.6181
age	false	0.5051
##########END##########
46
making decisions using nice guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.
T4
T3
T2
nice guidelines	false	0.8351
T1
st	false	1.3333
guidelines	false	1.3312
explain	false	1.0
form	false	1.0
recommendation	false	0.8769
consent	false	0.7615999999999999
##########END##########
47
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
48
last updated april 2018 explore treatment options in an atmosphere of hope and optimism, explaining the different courses of depression and that recovery is possible be aware that stigma and discrimination can be associated with a diagnosis of depression ensure that discussions take place in settings in which confidentiality, privacy and dignity are respected.
T4
T3
T2
treatment options	false	1.2636
T1
atmosphere	true	1.0
discrimination	true	1.0
discussions	true	1.0
hope	true	1.0
optimism	true	1.0
recovery	true	1.0
stigma	true	1.0
st	false	1.3333
settings	false	1.0917
diagnosis	false	1.0229
courses	false	1.0
dignity	false	1.0
explain	false	1.0
privacy	false	1.0
update	false	1.0
ect	false	0.6640999999999999
ensure	false	0.6597
place	false	0.5915
confidentiality	false	0.5530999999999999
##########END##########
49
when working with people with depression and their families or carers: provide information appropriate to their level of understanding about the nature of depression and the range of treatments available avoid clinical language without adequate explanation ensure that comprehensive written information is available in the appropriate language and in audio format if possible provide and work proficiently with independent interpreters (that is, someone who is not known to the person with depression) if needed.
T4
T3
comprehensive written information	false	0.5039
T2
T1
language	true	1.373
st	false	1.3333
form	false	1.0
work	false	1.0
carer	false	0.9221000000000001
plan	false	0.7734
families	false	0.6791999999999999
ensure	false	0.6597
##########END##########
50
inform people with depression about self-help groups, support groups and other local and national resources.
T4
T3
T2
national resources	true	0.7274
inform people	false	0.7274
self-help groups	false	0.7274
T1
groups	true	0.6314
##########END##########
51
ensure that consent to treatment is based on the provision of clear information (which should also be available in written form) about the intervention, covering: what it comprises what is expected of the person while having it likely outcomes (including any side effects).
T4
T3
T2
clear information	false	1.2263
written form	false	1.2263
T1
outcomes	true	0.9002
consent	false	0.7615999999999999
intervention	false	0.6759
ect	false	0.6640999999999999
ensure	false	0.6597
provision	false	0.6004999999999999
##########END##########
52
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
53
for people with recurrent severe depression or depression with psychotic symptoms and for those who have been treated under the mental health act, consider developing advance decisions and advance statements collaboratively with the person
T4
T3
T2
mental health	true	0.5534999999999999
T1
st	false	1.3333
advance	false	0.8785999999999999
iv	false	0.5482
##########END##########
54
when families or carers are involved in supporting a person with severe or chronic  depression, consider: providing written and verbal information on depression and its management, including how families or carers can support the person offering a carer's assessment of their caring, physical and mental health needs if necessary providing information about local family or carer support groups and voluntary organisations, and helping families or carers to access these negotiating between the person and their family or carer about confidentiality and the sharing of information.
T4
T3
T2
mental health	true	0.5534999999999999
T1
groups	true	0.6314
family	true	0.5555999999999999
form	false	1.0
carer	false	0.9221000000000001
families	false	0.6791999999999999
assessment	false	0.6628000000000001
confidentiality	false	0.5530999999999999
access	false	0.5051
age	false	0.5051
##########END##########
55
principles for assessment, coordination of care and choosing treatments
T4
T3
T2
T1
assessment	false	0.6628000000000001
care	false	0.5497000000000001
##########END##########
56
when assessing a person who may have depression, conduct a comprehensive assessment that does not rely simply on a symptom count
T4
T3
T2
T1
assessment	false	0.6628000000000001
iv	false	0.5482
##########END##########
57
in addition to assessing symptoms and associated functional impairment, consider how the following factors may have affected the development, course and severity of a person's depression: any history of depression and comorbid mental health or physical disorders any past history of mood elevation (to determine if the depression may be part of bipolar disorder )
T4
T3
T2
mental health	true	0.5534999999999999
T1
disorder	true	0.8392999999999999
severity	true	0.6433
st	false	1.3333
term	false	1.0
ect	false	0.6640999999999999
mood	false	0.6365000000000001
part	false	0.6348
##########END##########
58
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
59
be respectful of, and sensitive to, diverse cultural, ethnic and religious backgrounds when working with people with depression, and be aware of the possible variations in the presentation of depression
T4
T3
T2
T1
backgrounds	false	1.3333
work	false	1.0
ect	false	0.6640999999999999
iv	false	0.5482
##########END##########
60
ensure competence in: culturally sensitive assessment using different explanatory models of depression addressing cultural and ethnic differences when developing and implementing treatment plans working with families from diverse ethnic and cultural backgrounds.
T4
T3
T2
treatment plan	false	1.1966999999999999
T1
backgrounds	false	1.3333
work	false	1.0
competence	false	0.9177999999999998
plan	false	0.7734
families	false	0.6791999999999999
assessment	false	0.6628000000000001
ensure	false	0.6597
model	false	0.648
iv	false	0.5482
##########END##########
61
when assessing a person with suspected depression, be aware of any learning disabilities or acquired cognitive impairments, and if necessary consider consulting with a relevant specialist when developing treatment plans and strategies.
T4
T3
T2
cognitive impairment	true	0.7129999999999999
suspected depression	false	1.2636
relevant specialist	false	1.2263
treatment plan	false	1.1966999999999999
T1
st	false	1.3333
consulting	false	1.0
disabilities	false	1.0
##########END##########
62
when providing interventions for people with a learning disability or acquired cognitive impairment who have a diagnosis of depression: where possible, provide the same interventions as for other people with depression if necessary, adjust the method of delivery or duration of the intervention to take account of the disability or impairment.
T4
T3
T2
cognitive impairment	true	0.7129999999999999
T1
account	true	0.8969999999999999
delivery	true	0.5469999999999999
st	false	1.3333
disability	false	1.2241
diagnosis	false	1.0229
intervention	false	0.6759
method	false	0.5469999999999999
##########END##########
63
if there is a risk of self-harm or suicide: assess whether the person has adequate social support and is aware of sources of help arrange help appropriate to the level of risk (see section ) advise the person to seek further help if the situation deteriorates.
T4
T3
T2
T1
suicide	true	0.7382000000000001
advise	false	0.7478
self-harm	false	0.7046
ect	false	0.6640999999999999
##########END##########
64
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
65
all interventions for depression should be delivered by competent practitioners.
T4
T3
T2
competent practitioner	false	1.2263
T1
intervention	false	0.6759
iv	false	0.5482
##########END##########
66
psychological and psychosocial interventions should be based on the relevant treatment manual(s), which should guide the structure and duration of the intervention
T4
T3
relevant treatment manual(s)	false	1.5562
T2
T1
st	false	1.3333
intervention	false	0.6759
##########END##########
67
practitioners should consider using competence frameworks developed from the relevant treatment manual(s) and for all interventions should: receive regular high-quality supervision use routine outcome measures and ensure that the person with depression is involved in reviewing the efficacy of the treatment engage in monitoring and evaluation of treatment adherence and practitioner competence – for example, by using video and audio tapes, and external audit and scrutiny where appropriate.
T4
T3
relevant treatment manual(s)	false	1.5562
T2
outcome measure	false	0.7273
T1
review	true	0.5482
work	false	1.0
competence	false	0.9177999999999998
intervention	false	0.6759
ensure	false	0.6597
practitioners	false	0.5533
iv	false	0.5482
age	false	0.5051
##########END##########
68
the stepped-care model provides a framework in which to organise the provision of services, and supports patients, carers and practitioners in identifying and accessing the most effective interventions (see figure 1)
T4
T3
T2
T1
st	false	1.3333
work	false	1.0
carer	false	0.9221000000000001
services	false	0.6929000000000001
patients	false	0.6765000000000001
intervention	false	0.6759
ect	false	0.6640999999999999
model	false	0.648
provision	false	0.6004999999999999
practitioners	false	0.5533
care	false	0.5497000000000001
iv	false	0.5482
access	false	0.5051
##########END##########
69
in stepped care the least intrusive, most effective intervention is provided first; if a person does not benefit from the intervention initially offered, or declines an intervention, they should be offered an appropriate intervention from the next step.
T4
T3
T2
T1
st	false	1.3333
intervention	false	0.6759
ect	false	0.6640999999999999
care	false	0.5497000000000001
iv	false	0.5482
##########END##########
70
step 4: severe and complex[a] depression; risk to life; severe self-neglect
T4
T3
T2
T1
st	false	1.3333
self-neglect	false	1.0
##########END##########
71
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
72
medication, high-intensity psychological interventions, combined treatments, collaborative care[b] and referral for further assessment and interventions
T4
T3
high-intensity psychological intervention	false	1.0919
T2
collaborative care	false	1.0471
T1
referral	false	1.3978
intervention	false	0.6759
assessment	false	0.6628000000000001
##########END##########
73
low-intensity psychosocial interventions, psychological interventions, medication and referral for further assessment and interventions
T4
T3
low-intensity psychosocial interventions	false	1.3333
T2
psychological intervention	false	1.0532
T1
referral	false	1.3978
intervention	false	0.6759
assessment	false	0.6628000000000001
##########END##########
74
assessment, support, psychoeducation, active monitoring and referral for further assessment and interventions [a] complex depression includes depression that shows an inadequate response to multiple treatments, is complicated by psychotic symptoms, and/or is associated with significant psychiatric comorbidity or psychosocial factors. [b] only for depression where the person also has a chronic physical health problem and associated functional impairment (see depression in adults with a chronic physical health problem: recognition and management [nice clinical guideline 91]).
T4
chronic physical health problem	false	0.7096999999999999
T3
nice clinical guideline	false	0.6939
T2
active monitoring	false	0.6098999999999999
T1
referral	false	1.3978
intervention	false	0.6759
assessment	false	0.6628000000000001
age	false	0.5051
##########END##########
75
step 1: recognition, assessment and initial management
T4
T3
T2
T1
st	false	1.3333
assessment	false	0.6628000000000001
age	false	0.5051
##########END##########
76
be alert to possible depression (particularly in people with a past history of depression or a chronic physical health problem with associated functional impairment) and consider asking people who may have depression two questions, specifically:
T4
chronic physical health problem	false	0.7096999999999999
T3
T2
T1
st	false	1.3333
part	false	0.6348
##########END##########
77
if a person answers 'yes' to either of the depression identification questions (see recommendation ) but the practitioner is not competent to perform a mental health assessment, they should refer the person to an appropriate professional
T4
T3
depression identification questions	false	1.0522
mental health assessment	false	1.0522
T2
person answers	false	1.0003000000000002
T1
form	false	1.0
refer	false	1.0
recommendation	false	0.8769
##########END##########
78
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
79
if a person answers 'yes' to either of the depression identification questions (see recommendation ), a practitioner who is competent to perform a mental health assessment should review the person's mental state and associated functional, interpersonal and social difficulties.
T4
T3
depression identification questions	false	1.0522
mental health assessment	false	1.0522
T2
person answers	false	1.0003000000000002
T1
review	true	0.5482
st	false	1.3333
form	false	1.0
recommendation	false	0.8769
difficulties	false	0.5496
##########END##########
80
when assessing a person with suspected depression, consider using a validated measure (for example, for symptoms, functions and/or disability) to inform and evaluate treatment.
T4
T3
T2
suspected depression	false	1.2636
T1
disability	false	1.2241
form	false	1.0
functions	false	1.0
measure	false	0.8664999999999999
##########END##########
81
for people with significant language or communication difficulties, for example people with sensory impairments or a learning disability, consider using the
T4
T3
T2
communication difficulties	false	1.2237
sensory impairments	false	1.2237
significant language	false	1.2237
T1
disability	false	1.2241
##########END##########
82
risk assessment and monitoring
T4
T3
T2
risk assessment	false	1.2237
T1
##########END##########
83
if a person with depression presents considerable immediate risk to themselves or others, refer them urgently to specialist mental health services.
T4
specialist mental health services	false	1.0856
T3
T2
T1
refer	false	1.0
media	false	0.5051
##########END##########
84
advise people with depression of the potential for increased agitation, anxiety and suicidal ideation in the initial stages of treatment; actively seek out these symptoms and: ensure that the person knows how to seek help promptly review the person's treatment if they develop marked and/or prolonged agitation.
T4
T3
T2
suicidal ideation	false	0.8665
advise people	false	0.5146000000000001
initial stages	false	0.5146000000000001
prolonged agitation	false	0.5146000000000001
T1
agitation	true	1.1081
anxiety	true	0.8421000000000001
review	true	0.5482
ensure	false	0.6597
iv	false	0.5482
##########END##########
85
advise a person with depression and their family or carer to be vigilant for mood changes, negativity and hopelessness, and suicidal ideation, and to contact their practitioner if concerned
T4
T3
T2
suicidal ideation	false	0.8665
T1
hope	true	1.0
changes	true	0.9602
family	true	0.5555999999999999
negativity	false	0.9602
carer	false	0.9221000000000001
advise	false	0.7478
contact	false	0.7024999999999999
mood	false	0.6365000000000001
##########END##########
86
if a person with depression is assessed to be at risk of suicide: take into account toxicity in overdose if an antidepressant is prescribed or the person is taking other medication; if necessary, limit the amount of drug(s) available
T4
T3
T2
account toxicity	false	1.1814
T1
overdose	true	1.3507
suicide	true	0.7382000000000001
drug	true	0.5234
amount	false	0.9602
##########END##########
87
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
88
last updated april 2018 consider increasing the level of support, such as more frequent direct or telephone contacts consider referral to specialist mental health services.
T4
specialist mental health services	false	1.0856
T3
T2
frequent direct	false	1.1814
telephone contacts	false	1.1814
T1
referral	false	1.3978
st	false	1.3333
update	false	1.0
##########END##########
89
general measures
T4
T3
T2
T1
measure	false	0.8664999999999999
##########END##########
90
when depression is accompanied by symptoms of anxiety, the first priority should usually be to treat the depression
T4
T3
T2
T1
anxiety	true	0.8421000000000001
st	false	1.3333
##########END##########
91
when the person has an anxiety disorder and comorbid depression or depressive symptoms, consult the nice guideline for the relevant anxiety disorder (see find guidance) and consider treating the anxiety disorder first (since effective treatment of the anxiety disorder will often improve the depression or the depressive symptoms).
T4
T3
T2
anxiety disorder	true	1.7275
depressive symptoms	false	0.5397
T1
st	false	1.3333
guidance	false	0.7817999999999999
ect	false	0.6640999999999999
guideline	false	0.6181
iv	false	0.5482
##########END##########
92
offer people with depression advice on sleep hygiene if needed, including: establishing regular sleep and wake times avoiding excess eating, smoking or drinking alcohol before sleep creating a proper environment for sleep taking regular physical exercise.
T4
T3
T2
T1
sleep	false	1.6
st	false	1.3333
time	false	0.6736
##########END##########
93
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
94
last updated april 2018 provide information about the nature and course of depression arrange a further assessment, normally within 2 weeks make contact if the person does not attend follow-up appointments.
T4
T3
T2
follow-up appointments	false	1.2263
T1
st	false	1.3333
form	false	1.0
update	false	1.0
contact	false	0.7024999999999999
assessment	false	0.6628000000000001
##########END##########
95
for people with persistent subthreshold depressive symptoms or mild to moderate depression, consider offering one or more of the following interventions, guided by the person's preference: individual guided self-help based on the principles of cognitive behavioural therapy (cbt) computerised cognitive behavioural therapy (ccbt) a structured group physical activity programme.
T4
group physical activity programme	false	0.5826
T3
cognitive behavioural therapy	false	1.2946
subthreshold depressive symptoms	false	0.6527999999999999
T2
T1
st	false	1.3333
refer	false	1.0
self-help	false	0.7616999999999999
intervention	false	0.6759
iv	false	0.5482
##########END##########
96
individual guided self-help programmes based on the principles of cbt (and including behavioural activation and problem-solving techniques) for people with persistent subthreshold depressive symptoms or mild to moderate depression should: include the provision of written materials of an appropriate reading age (or alternative media to support access) be supported by a trained practitioner, who typically facilitates the self-help programme and reviews progress and outcome consist of up to six to eight sessions (face-to-face and via telephone) normally taking place over 9 to 12 weeks, including follow-up.
T4
T3
subthreshold depressive symptoms	false	0.6527999999999999
T2
reviews progress	false	0.7194
trained practitioner	false	0.7194
alternative media	false	0.6542
reading age	false	0.6542
self-help programme	false	0.6542
written materials	false	0.6542
behavioural activation	false	0.6527999999999999
T1
st	false	1.3333
sessions	false	1.2136
problem	false	0.6767
provision	false	0.6004999999999999
place	false	0.5915
outcome	false	0.5861000000000001
iv	false	0.5482
access	false	0.5051
techniques	false	0.5051
##########END##########
97
ccbt for people with persistent subthreshold depressive symptoms or mild to moderate depression should: be provided via a stand-alone computer-based or web-based programme include an explanation of the cbt model, encourage tasks between sessions, and use thought-challenging and active monitoring of behaviour, thought patterns and
T4
T3
subthreshold depressive symptoms	false	0.6527999999999999
T2
cbt model	false	0.7993999999999999
stand-alone computer-based	false	0.7993999999999999
web-based programme	false	0.7993999999999999
active monitoring	false	0.6098999999999999
T1
st	false	1.3333
sessions	false	1.2136
plan	false	0.7734
patterns	false	0.631
tasks	false	0.631
thought-challenging	false	0.631
age	false	0.5051
##########END##########
98
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
99
last updated april 2018 outcomes be supported by a trained practitioner, who typically provides limited facilitation of the programme and reviews progress and outcome typically take place over 9 to 12 weeks, including follow-up.
T4
T3
T2
limited facilitation	false	0.7993999999999999
reviews progress	false	0.7194
trained practitioner	false	0.7194
T1
outcomes	true	0.9002
st	false	1.3333
update	false	1.0
programme	false	0.7277999999999999
place	false	0.5915
outcome	false	0.5861000000000001
##########END##########
100
physical activity programmes for people with persistent subthreshold depressive symptoms or mild to moderate depression should: be delivered in groups with support from a competent practitioner consist typically of three sessions per week of moderate duration (45 minutes to 1 hour) over 10 to 14 weeks (average 12 weeks).
T4
T3
physical activity programmes	false	1.3333
subthreshold depressive symptoms	false	0.6527999999999999
T2
competent practitioner	false	1.2263
moderate duration	false	1.2263
T1
groups	true	0.6314
st	false	1.3333
sessions	false	1.2136
average	false	1.0
hour	false	1.0
minutes	false	1.0
iv	false	0.5482
##########END##########
101
consider group-based cbt for people with persistent subthreshold depressive symptoms or mild to moderate depression who decline low-intensity psychosocial interventions (see recommendation ).
T4
T3
low-intensity psychosocial interventions	false	1.3333
subthreshold depressive symptoms	false	0.6527999999999999
T2
group-based cbt	false	1.2636
T1
st	false	1.3333
recommendation	false	0.8769
##########END##########
102
group-based cbt for people with persistent subthreshold depressive symptoms or mild to moderate depression should: be based on a structured model such as 'coping with depression' be delivered by two trained and competent practitioners consist of 10 to 12 meetings of eight to ten participants normally take place over 12 to 16 weeks, including follow-up.
T4
T3
subthreshold depressive symptoms	false	0.6527999999999999
T2
group-based cbt	false	1.2636
competent practitioner	false	1.2263
structured model	false	1.2263
T1
st	false	1.3333
coping	false	1.0
part	false	0.6348
place	false	0.5915
iv	false	0.5482
meetings	false	0.5330999999999999
##########END##########
103
do not use antidepressants routinely to treat persistent subthreshold depressive symptoms or mild depression because the risk–benefit ratio is poor, but consider them for people with: a past history of moderate or severe depression or initial presentation of subthreshold depressive symptoms that have been present for a long period (typically at least 2 years) or
T4
T3
subthreshold depressive symptoms	false	0.6527999999999999
T2
mild depression	false	0.8528000000000001
T1
st	false	1.3333
antidepressants	false	0.7967
period	false	0.7526
##########END##########
104
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
105
although there is evidence that st john's wort may be of benefit in mild or moderate depression, practitioners should: not prescribe or advise its use by people with depression because of uncertainty about appropriate doses, persistence of effect, variation in the nature of preparations and potential serious interactions with other drugs (including oral contraceptives, anticoagulants and anticonvulsants) advise people with depression of the different potencies of the preparations available and of the potential serious interactions of st john's wort with other drugs.
T4
T3
john's wort	false	1.6
T2
advise people	false	0.5146000000000001
T1
preparations	true	1.3333
drug	true	0.5234
st	false	1.3333
dose	false	1.1499
evidence	false	0.7991999999999999
advise	false	0.7478
ect	false	0.6640999999999999
interactions	false	0.6349000000000001
practitioners	false	0.5533
iv	false	0.5482
##########END##########
106
for people with persistent subthreshold depressive symptoms or mild to moderate depression who have not benefited from a low-intensity psychosocial intervention, discuss the relative merits of different interventions with the person and provide: an antidepressant (normally a selective serotonin reuptake inhibitor [ssri]) or a high-intensity psychological intervention, normally one of the following options:
T4
T3
high-intensity psychological intervention	false	1.0919
subthreshold depressive symptoms	false	0.6527999999999999
T2
T1
ssri	true	0.6744999999999999
st	false	1.3333
intensity	false	0.9704
options	false	0.791
intervention	false	0.6759
ect	false	0.6640999999999999
iv	false	0.5482
##########END##########
107
ipt) behavioural couples therapy for people who have a regular partner and where the relationship may contribute to the development or maintenance of depression, or where involving the partner is considered to be of potential therapeutic benefit.
T4
T3
T2
behavioural couples	false	0.8605
T1
partner	false	1.3333
ipt	false	0.7725000000000001
##########END##########
108
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
109
for people with moderate or severe depression, provide a combination of antidepressant medication and a high-intensity psychological intervention (cbt or ipt).
T4
T3
high-intensity psychological intervention	false	1.0919
T2
antidepressant medication	false	0.8141
T1
ipt	false	0.7725000000000001
combination	false	0.6143
##########END##########
110
the choice of intervention should be influenced by the: duration of the episode of depression and the trajectory of symptoms previous course of depression and response to treatment likelihood of adherence to treatment and any potential adverse effects person's treatment preference and priorities.
T4
T3
potential adverse effects	false	1.3333
T2
symptoms previous	false	1.2263
treatment likelihood	false	1.2263
treatment preference	false	1.2263
T1
choice	true	0.6835000000000001
episode	false	1.0
priorities	false	1.0
trajectory	false	1.0
intervention	false	0.6759
##########END##########
111
for people with depression who decline an antidepressant, cbt, ipt, behavioural activation and behavioural couples therapy, consider: counselling for people with persistent subthreshold depressive symptoms or mild to moderate depression short-term psychodynamic psychotherapy for people with mild to moderate depression.
T4
T3
short-term psychodynamic psychotherapy	false	1.4660000000000002
subthreshold depressive symptoms	false	0.6527999999999999
T2
behavioural couples	false	0.8605
behavioural activation	false	0.6527999999999999
T1
st	false	1.3333
ipt	false	0.7725000000000001
##########END##########
112
discuss antidepressant treatment options with the person with depression, covering: the choice of antidepressant, including any anticipated adverse events, for example side effects and discontinuation symptoms (see recommendation ), and potential interactions with concomitant medication or physical health problems their perception of the efficacy and tolerability of any antidepressants they have previously taken.
T4
T3
anticipated adverse events	false	1.3333
antidepressant treatment options	false	1.3333
physical health problems	false	1.3333
T2
concomitant medication	false	1.2636
potential interactions	false	1.2263
discontinuation symptoms	false	0.728
T1
choice	true	0.6835000000000001
perception	false	1.0
tolerability	false	1.0
recommendation	false	0.8769
antidepressants	false	0.7967
ect	false	0.6640999999999999
##########END##########
113
when an antidepressant is to be prescribed, it should normally be an ssri in a
T4
T3
T2
T1
ssri	true	0.6744999999999999
##########END##########
114
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
115
in particular, consider prescribing a gastroprotective drug in older people who are taking non-steroidal anti-inflammatory drugs (nsaids) or aspirin.
T4
T3
non-steroidal anti-inflammatory drugs	false	1.3333
T2
gastroprotective drug	false	1.2263
T1
aspirin	false	1.0
nsaids	false	1.0
part	false	0.6348
##########END##########
116
be aware that: compared with other equally effective antidepressants recommended for routine use in primary care, venlafaxine is associated with a greater risk of death from overdose tricyclic antidepressants (tcas), except for lofepramine, are associated with the greatest risk in overdose.
T4
T3
overdose tricyclic antidepressants	false	0.5589000000000001
T2
T1
overdose	true	1.3507
venlafaxine	true	0.5322000000000001
st	false	1.3333
antidepressants	false	0.7967
ect	false	0.6640999999999999
care	false	0.5497000000000001
iv	false	0.5482
##########END##########
117
for example: the potential for higher doses of venlafaxine to exacerbate cardiac arrhythmias and the need to monitor the person's blood pressure the possible exacerbation of hypertension with venlafaxine and duloxetine the potential for postural hypotension and arrhythmias with tcas the need for haematological monitoring with mianserin in elderly people.
T4
T3
T2
T1
mianserin	true	0.6857
venlafaxine	true	0.5322000000000001
arrhythmias	false	1.3333
st	false	1.3333
dose	false	1.1499
##########END##########
118
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
119
non-reversible monoamine oxidase inhibitors (maois), such as phenelzine, should normally be prescribed only by specialist mental health professionals.
T4
non-reversible monoamine oxidase inhibitors	false	1.3979
specialist mental health professionals	false	1.3979
T3
T2
T1
phenelzine	true	1.0
maois	false	1.0
##########END##########
120
dosulepin should not be prescribed.
T4
T3
T2
T1
dosulepin	true	1.0
##########END##########
121
when prescribing antidepressants, explore any concerns the person with depression has about taking medication, explain fully the reasons for prescribing, and provide information about taking antidepressants, including: the gradual development of the full antidepressant effect the importance of taking medication as prescribed and the need to continue treatment after remission potential side effects the potential for interactions with other medications the risk and nature of discontinuation symptoms with all antidepressants, particularly with drugs with a shorter half-life (such as paroxetine and venlafaxine), and how these symptoms can be minimised the fact that addiction does not occur with antidepressants.
T4
T3
T2
discontinuation symptoms	false	0.728
T1
venlafaxine	true	0.5322000000000001
drug	true	0.5234
explain	false	1.0
form	false	1.0
antidepressants	false	0.7967
medications	false	0.6773
ect	false	0.6640999999999999
interactions	false	0.6349000000000001
part	false	0.6348
##########END##########
122
for people started on antidepressants who are not considered to be at increased risk of suicide, normally see them after 2 weeks
T4
T3
T2
T1
suicide	true	0.7382000000000001
st	false	1.3333
antidepressants	false	0.7967
##########END##########
123
a person with depression started on antidepressants who is considered to present an increased suicide risk or is younger than 30 years (because of the potential increased prevalence of suicidal thoughts in the early stages of antidepressant treatment for this group) should normally be seen after 1 week and frequently thereafter as appropriate until the risk is no longer considered clinically important.
T4
T3
T2
antidepressant treatment	false	1.1678000000000002
early stages	false	0.6906000000000001
suicidal thoughts	false	0.6906000000000001
suicide risk	false	0.5582000000000001
T1
st	false	1.3333
antidepressants	false	0.7967
prevalence	false	0.5274000000000001
##########END##########
124
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
125
last updated april 2018 treatment, provide appropriate information and consider one of the following strategies: monitor symptoms closely where side effects are mild and acceptable to the person or stop the antidepressant or change to a different antidepressant if the person prefers or in discussion with the person, consider short-term concomitant treatment with a benzodiazepine if anxiety, agitation and/or insomnia are problematic (except in people with chronic symptoms of anxiety); this should usually be for no longer than 2 weeks in order to prevent the development of dependence.
T4
T3
short-term concomitant treatment	false	0.7887000000000001
T2
chronic symptoms	false	0.7187
T1
agitation	true	1.1081
anxiety	true	0.8421000000000001
insomnia	true	0.563
st	false	1.3333
form	false	1.0
refer	false	1.0
update	false	1.0
problem	false	0.6767
ect	false	0.6640999999999999
order	false	0.5977
change	false	0.563
discussion	false	0.563
##########END##########
126
people who start on low-dose tcas and who have a clear clinical response can be maintained on that dose with careful monitoring. 0 if the person's depression shows no improvement after 2 to 4 weeks with the first antidepressant, check that the drug has been taken regularly and in the prescribed dose. 1 if response is absent or minimal after 3 to 4 weeks of treatment with a therapeutic dose of an antidepressant, increase the level of support (for example, by weekly face-to-face or telephone contact) and consider: increasing the dose in line with the spc if there are no significant side effects or switching to another antidepressant as described in section if there are side effects or if the person prefers. 2 if the person's depression shows some improvement by 4 weeks, continue treatment for another 2 to 4 weeks
T4
T3
T2
T1
check	true	0.5690999999999999
spc	true	0.5423
drug	true	0.5234
st	false	1.3333
dose	false	1.1499
refer	false	1.0
contact	false	0.7024999999999999
ect	false	0.6640999999999999
care	false	0.5497000000000001
##########END##########
127
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
128
for all high-intensity psychological interventions, the duration of treatment should normally be within the limits indicated in this guideline
T4
T3
high-intensity psychological intervention	false	1.0919
T2
T1
guideline	false	0.6181
##########END##########
129
for all people with depression having individual cbt, the duration of treatment should typically be in the range of 16 to 20 sessions over 3 to 4 months
T4
T3
T2
T1
sessions	false	1.2136
months	false	0.651
iv	false	0.5482
##########END##########
130
also consider providing: two sessions per week for the first 2 to 3 weeks of treatment for people with moderate or severe depression follow-up sessions typically consisting of three to four sessions over the following 3 to 6 months for all people with depression.
T4
T3
T2
T1
st	false	1.3333
sessions	false	1.2136
months	false	0.651
##########END##########
131
for all people with depression having ipt, the duration of treatment should typically be in the range of 16 to 20 sessions over 3 to 4 months
T4
T3
T2
T1
sessions	false	1.2136
ipt	false	0.7725000000000001
months	false	0.651
##########END##########
132
for people with severe depression, consider providing two sessions per week for the first 2 to 3 weeks of treatment.
T4
T3
T2
T1
st	false	1.3333
sessions	false	1.2136
##########END##########
133
for all people with depression having behavioural activation, the duration of treatment should typically be in the range of 16 to 20 sessions over 3 to 4 months
T4
T3
T2
behavioural activation	false	0.6527999999999999
T1
sessions	false	1.2136
months	false	0.651
##########END##########
134
also consider providing: two sessions per week for the first 3 to 4 weeks of treatment for people with moderate or severe depression follow-up sessions typically consisting of three to four sessions over the following 3 to 6 months for all people with depression.
T4
T3
T2
T1
st	false	1.3333
sessions	false	1.2136
months	false	0.651
##########END##########
135
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
136
behavioural couples therapy for depression should normally be based on behavioural principles, and an adequate course of therapy should be 15 to 20 sessions over 5 to 6 months.
T4
T3
T2
behavioural principles	false	1.1690999999999998
behavioural couples	false	0.8605
T1
sessions	false	1.2136
months	false	0.651
##########END##########
137
for all people with persistent subthreshold depressive symptoms or mild to moderate depression having counselling, the duration of treatment should typically be in the range of six to ten sessions over 8 to 12 weeks.
T4
T3
subthreshold depressive symptoms	false	0.6527999999999999
T2
T1
st	false	1.3333
sessions	false	1.2136
##########END##########
138
for all people with mild to moderate depression having short-term psychodynamic psychotherapy, the duration of treatment should typically be in the range of 16 to 20 sessions over 4 to 6 months.
T4
T3
short-term psychodynamic psychotherapy	false	1.4660000000000002
T2
T1
sessions	false	1.2136
months	false	0.651
##########END##########
139
refer to 'depression in adults with a chronic physical health problem: recognition and management' (nice clinical guideline 91) for further information.
T4
chronic physical health problem	false	0.7096999999999999
T3
nice clinical guideline	false	0.6939
T2
T1
form	false	1.0
refer	false	1.0
age	false	0.5051
##########END##########
140
when prescribing antidepressants for older people: prescribe at an age-appropriate dose taking into account the effect of general physical health and concomitant medication on pharmacokinetics and pharmacodynamics
T4
T3
general physical health	false	1.3333
T2
concomitant medication	false	1.2636
age-appropriate dose	false	1.2263
T1
account	true	0.8969999999999999
pharmacodynamics	false	1.0
pharmacokinetics	false	1.0
antidepressants	false	0.7967
ect	false	0.6640999999999999
##########END##########
141
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
142
for people with long-standing moderate or severe depression who would benefit from additional social or vocational support, consider: befriending as an adjunct to pharmacological or psychological treatments; befriending should be by trained volunteers providing, typically, at least weekly contact for between 2 and 6 months a rehabilitation programme if a person's depression has resulted in loss of work or disengagement from other social activities over a longer term.
T4
T3
T2
additional social	false	1.2263
long-standing moderate	false	1.2263
psychological treatment	false	1.2263
rehabilitation programme	false	1.2263
social activities	false	1.2263
trained volunteers	false	1.2263
vocational support	false	1.2263
weekly contact	false	1.2263
T1
loss	true	1.0
st	false	1.3333
adjunct	false	1.0
disengagement	false	1.0
term	false	1.0
work	false	1.0
months	false	0.651
##########END##########
143
medication management as a separate intervention for people with depression should not be provided routinely by services
T4
T3
T2
medication management	false	1.1690999999999998
separate intervention	false	1.1690999999999998
T1
services	false	0.6929000000000001
##########END##########
144
it is likely to be effective only when provided as part of a more complex intervention.
T4
T3
T2
complex intervention	false	1.1690999999999998
T1
ect	false	0.6640999999999999
part	false	0.6348
iv	false	0.5482
##########END##########
145
for people with severe depression and those with moderate depression and complex problems, consider: referring to specialist mental health services for a programme of coordinated multiprofessional care providing collaborative care if the depression is in the context of a chronic physical health problem with associated functional impairment .
T4
specialist mental health services	false	1.0856
chronic physical health problem	false	0.7096999999999999
T3
T2
multiprofessional care	false	1.1682000000000001
collaborative care	false	1.0471
complex problems	false	1.0471
T1
refer	false	1.0
context	false	0.9786000000000001
programme	false	0.7277999999999999
##########END##########
146
when reviewing drug treatment for a person with depression whose symptoms have not adequately responded to initial pharmacological interventions: check adherence to, and side effects from, initial treatment increase the frequency of appointments using outcome monitoring with a validated
T4
T3
initial pharmacological interventions	false	0.7986000000000001
T2
drug treatment	false	0.9954999999999999
check adherence	false	0.7273
initial treatment	false	0.7273
outcome monitoring	false	0.7273
T1
review	true	0.5482
appointments	false	0.8664999999999999
ect	false	0.6640999999999999
frequency	false	0.5690999999999999
##########END##########
147
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
148
last updated april 2018 outcome measure be aware that using a single antidepressant rather than combination medication or augmentation (see recommendations to ) is usually associated with a lower side-effect burden consider reintroducing previous treatments that have been inadequately delivered or adhered to, including increasing the dose consider switching to an alternative antidepressant.
T4
T3
T2
previous treatments	false	1.2265
alternative antidepressant	false	0.7273
combination medication	false	0.7273
outcome measure	false	0.7273
single antidepressant	false	0.7273
side-effect burden	false	0.6946
T1
st	false	1.3333
dose	false	1.1499
update	false	1.0
augmentation	false	0.9315
recommendation	false	0.8769
iv	false	0.5482
##########END##########
149
when switching to another antidepressant, be aware that the evidence for the relative advantage of switching either within or between classes is weak.
T4
T3
T2
relative advantage	false	1.2263
T1
classes	false	1.0
evidence	false	0.7991999999999999
##########END##########
150
when switching to another antidepressant, which can normally be achieved within 1 week when switching from drugs with a short half-life, consider the potential for interactions in determining the choice of new drug and the nature and duration of the transition
T4
T3
T2
short half-life	false	0.5758
T1
choice	true	0.6835000000000001
drug	true	0.5234
term	false	1.0
interactions	false	0.6349000000000001
##########END##########
151
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
152
last updated april 2018 from a non-reversible maoi: a 2-week washout period is required (other antidepressants should not be prescribed routinely during this period).
T4
T3
2-week washout period	false	0.6380999999999999
T2
non-reversible maoi	false	0.5758
T1
st	false	1.3333
update	false	1.0
antidepressants	false	0.7967
period	false	0.7526
##########END##########
153
when using combinations of medications (which should only normally be started in primary care in consultation with a consultant psychiatrist): select medications that are known to be safe when used together be aware of the increased side-effect burden this usually causes discuss the rationale for any combination with the person with depression, follow
T4
T3
T2
consultant psychiatrist	false	0.7863
side-effect burden	false	0.6946
T1
combinations	false	1.3333
rationale	false	1.3333
st	false	1.3333
medications	false	0.6773
ect	false	0.6640999999999999
combination	false	0.6143
care	false	0.5497000000000001
##########END##########
154
gmc guidance if off-label medication is prescribed, and monitor carefully for adverse effects be familiar with primary evidence and consider obtaining a second opinion when using unusual combinations, the evidence for the efficacy of a chosen strategy is limited or the risk–benefit ratio is unclear document the rationale for the chosen combination.
T4
T3
T2
adverse effects	false	0.7863
T1
combinations	false	1.3333
rationale	false	1.3333
st	false	1.3333
evidence	false	0.7991999999999999
guidance	false	0.7817999999999999
opinion	false	0.6786999999999999
combination	false	0.6143
care	false	0.5497000000000001
##########END##########
155
if a person with depression is informed about, and prepared to tolerate, the increased side-effect burden, consider combining or augmenting an antidepressant with: lithium or an antipsychotic such as aripiprazole*, olanzapine*, quetiapine* or risperidone* or another antidepressant such as mirtazapine or mianserin.
T4
T3
T2
side-effect burden	false	0.6946
T1
aripiprazole	true	1.0
mirtazapine	true	1.0
olanzapine	true	1.0
quetiapine	true	1.0
risperidone	true	1.0
mianserin	true	0.6857
form	false	1.0
##########END##########
156
when prescribing lithium: monitor renal and thyroid function before treatment and every 6 months during treatment (more often if there is evidence of renal impairment) consider ecg monitoring in people with depression who are at high risk of cardiovascular disease
T4
T3
T2
T1
evidence	false	0.7991999999999999
months	false	0.651
##########END##########
157
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
158
the following strategies should not be used routinely: augmentation of an antidepressant with a benzodiazepine for more than 2 weeks as there is a risk of dependence augmentation of an antidepressant with buspirone*, carbamazepine*, lamotrigine* or valproate * as there is insufficient evidence for their use augmentation of an antidepressant with pindolol* or thyroid hormones* as there is inconsistent evidence of effectiveness .
T4
T3
T2
T1
valproate	true	0.6819999999999999
st	false	1.3333
augmentation	false	0.9315
evidence	false	0.7991999999999999
effectiveness	false	0.6819999999999999
##########END##########
159
combined psychological and drug treatment 0 for a person whose depression has not responded to either pharmacological or psychological interventions, consider combining antidepressant medication with cbt.
T4
T3
T2
combined psychological	false	1.2263
psychological intervention	false	1.0532
drug treatment	false	0.9954999999999999
antidepressant medication	false	0.8141
T1
##########END##########
160
referral 1 for a person whose depression has failed to respond to various strategies for augmentation and combination treatments, consider referral to a practitioner with a specialist interest in treating depression, or to a specialist service.
T4
T3
T2
combination treatments	false	0.5104
specialist interest	false	0.5104
specialist service	false	0.5104
T1
referral	false	1.3978
st	false	1.3333
augmentation	false	0.9315
##########END##########
161
continuation and relapse prevention
T4
T3
T2
T1
relapse	false	0.7576999999999999
##########END##########
162
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
163
treatment choice should be influenced by: previous treatment history, including the consequences of a relapse, residual symptoms, response to previous treatment and any discontinuation symptoms the person's preference.
T4
T3
T2
residual symptoms	false	1.1971
previous treatment	false	1.073
discontinuation symptoms	false	0.728
T1
choice	true	0.6835000000000001
st	false	1.3333
refer	false	1.0
relapse	false	0.7576999999999999
##########END##########
164
using medication for relapse prevention
T4
T3
T2
T1
relapse	false	0.7576999999999999
##########END##########
165
people with depression on long-term maintenance treatment should be
T4
T3
T2
T1
term	false	1.0
##########END##########
166
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
167
people who have had multiple episodes of depression, and who have had a good response to treatment with an antidepressant and an augmenting agent, should remain on this combination after remission if they find the side effects tolerable and acceptable
T4
T3
T2
T1
agent	true	1.5
episode	false	1.0
ect	false	0.6640999999999999
combination	false	0.6143
##########END##########
168
if one medication is stopped, it should usually be the augmenting agent
T4
T3
T2
T1
agent	true	1.5
st	false	1.3333
##########END##########
169
lithium should not be used as a sole agent to prevent recurrence.
T4
T3
T2
T1
agent	true	1.5
##########END##########
170
psychological interventions for relapse prevention
T4
T3
T2
psychological intervention	false	1.0532
T1
relapse	false	0.7576999999999999
##########END##########
171
people with depression who are considered to be at significant risk of relapse (including those who have relapsed despite antidepressant treatment or who are unable or choose not to continue antidepressant treatment) or who have residual symptoms, should be offered one of the following psychological interventions: individual cbt for people who have relapsed despite antidepressant medication and for people with a significant history of depression and residual symptoms despite treatment mindfulness-based cognitive therapy for people who are currently well but have experienced three or more previous episodes of depression.
T4
T3
T2
residual symptoms	false	1.1971
antidepressant treatment	false	1.1678000000000002
psychological intervention	false	1.0532
antidepressant medication	false	0.8141
significant risk	false	0.7038
T1
st	false	1.3333
episode	false	1.0
relapse	false	0.7576999999999999
iv	false	0.5482
##########END##########
172
delivering psychological interventions for relapse prevention
T4
T3
T2
psychological intervention	false	1.0532
T1
relapse	false	0.7576999999999999
iv	false	0.5482
##########END##########
173
for all people with depression who are having individual cbt for relapse prevention, the duration of treatment should typically be in the range of 16 to 20 sessions over 3 to 4 months
T4
T3
T2
T1
sessions	false	1.2136
relapse	false	0.7576999999999999
months	false	0.651
iv	false	0.5482
##########END##########
174
if the duration of treatment needs to be extended to achieve remission it should: consist of two sessions per week for the first 2 to 3 weeks of treatment include additional follow-up sessions, typically consisting of four to six sessions over
T4
T3
T2
T1
st	false	1.3333
sessions	false	1.2136
##########END##########
175
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
176
last updated april 2018 the following 6 months. 0 mindfulness-based cognitive therapy should normally be delivered in groups of 8 to 15 participants and consist of weekly 2-hour meetings over 8 weeks and four follow-up sessions in the 12 months after the end of treatment.
T4
T3
T2
T1
groups	true	0.6314
st	false	1.3333
sessions	false	1.2136
hour	false	1.0
update	false	1.0
months	false	0.651
part	false	0.6348
iv	false	0.5482
meetings	false	0.5330999999999999
##########END##########
177
explain that symptoms are usually mild and self-limiting over about 1 week, but can be severe, particularly if the drug is stopped abruptly.
T4
T3
T2
T1
drug	true	0.5234
st	false	1.3333
explain	false	1.0
part	false	0.6348
##########END##########
178
inform the person that they should seek advice from their practitioner if they experience significant discontinuation symptoms
T4
T3
T2
discontinuation symptoms	false	0.728
T1
form	false	1.0
##########END##########
179
if discontinuation symptoms occur: monitor symptoms and reassure the person if symptoms are mild consider reintroducing the original antidepressant at the dose that was effective (or another antidepressant with a longer half-life from the same class) if symptoms are severe, and reduce the dose gradually while monitoring symptoms. 0 step 4: complex and severe depression
T4
T3
T2
discontinuation symptoms	false	0.728
T1
st	false	1.3333
dose	false	1.1499
ect	false	0.6640999999999999
iv	false	0.5482
##########END##########
180
referral to specialist mental health services should normally be for people with depression who are at significant risk of self-harm, have psychotic symptoms, require complex multiprofessional care, or where an expert opinion on treatment and management is needed.
T4
specialist mental health services	false	1.0856
T3
complex multiprofessional care	false	1.3333
T2
expert opinion	true	1.2263
significant risk	false	0.7038
T1
referral	false	1.3978
self-harm	false	0.7046
age	false	0.5051
##########END##########
181
the assessment of a person with depression referred to specialist mental health services should include: their symptom profile, suicide risk and, where appropriate, previous treatment history
T4
specialist mental health services	false	1.0856
T3
T2
previous treatment	false	1.073
suicide risk	false	0.5582000000000001
T1
st	false	1.3333
refer	false	1.0
assessment	false	0.6628000000000001
##########END##########
182
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
183
in specialist mental health services, after thoroughly reviewing previous treatments for depression, consider reintroducing previous treatments that have been inadequately delivered or adhered to.
T4
specialist mental health services	false	1.0856
T3
T2
previous treatments	false	1.2265
T1
review	true	0.5482
iv	false	0.5482
##########END##########
184
the teams should monitor risk as a high-priority routine activity in a way that allows people to continue their lives without disruption.
T4
T3
high-priority routine activity	false	1.3333
T2
T1
disruption	false	1.0
lives	false	1.0
teams	false	0.6266
##########END##########
185
medication in secondary care mental health services should be started under the supervision of a consultant psychiatrist.
T4
secondary care mental health	false	1.3979
T3
T2
consultant psychiatrist	false	0.7863
T1
st	false	1.3333
services	false	0.6929000000000001
##########END##########
186
teams working with people with complex and severe depression should develop comprehensive multidisciplinary care plans in collaboration with the person with depression (and their family or carer, if agreed with the person)
T4
T3
T2
T1
family	true	0.5555999999999999
work	false	1.0
carer	false	0.9221000000000001
plan	false	0.7734
teams	false	0.6266
care	false	0.5497000000000001
iv	false	0.5482
##########END##########
187
the care plan should: identify clearly the roles and responsibilities of all health and social care professionals involved develop a crisis plan that identifies potential triggers that could lead to a crisis and strategies to manage such triggers be shared with the gp and the person with depression and other relevant people involved in the person's care.
T4
T3
T2
T1
st	false	1.3333
crisis	false	1.1573
triggers	false	1.1573
plan	false	0.7734
professionals	false	0.6266
care	false	0.5497000000000001
age	false	0.5051
##########END##########
188
consider inpatient treatment for people with depression who are at significant risk of suicide, self-harm or self-neglect.
T4
T3
T2
inpatient treatment	false	1.2263
significant risk	false	0.7038
T1
suicide	true	0.7382000000000001
self-neglect	false	1.0
self-harm	false	0.7046
##########END##########
189
the full range of high-intensity psychological interventions should normally be offered in inpatient settings
T4
T3
high-intensity psychological intervention	false	1.0919
T2
full range	false	1.1966999999999999
inpatient settings	false	1.1966999999999999
T1
##########END##########
190
however, consider increasing the intensity and duration of the interventions and ensure that they can be provided effectively
T4
T3
T2
T1
intensity	false	0.9704
intervention	false	0.6759
ect	false	0.6640999999999999
ensure	false	0.6597
iv	false	0.5482
##########END##########
191
depression in adults: recognition and management (cg90) conditions#notice-of-rights)
T4
T3
T2
T1
age	false	0.5051
##########END##########
192
for people who have depression with psychotic symptoms, consider augmenting the current treatment plan with antipsychotic medication (although the optimum dose and duration of treatment are unknown).
T4
T3
current treatment plan	false	1.3037
T2
antipsychotic medication	false	1.1966999999999999
optimum dose	false	1.1966999999999999
T1
##########END##########
193
the recommendations in this section update the depression aspects only of 'guidance on the use of electroconvulsive therapy' (nice technology appraisal guidance 59).
T4
nice technology appraisal guidance	false	0.9053
T3
T2
depression aspects	false	0.7753
T1
update	false	1.0
recommendation	false	0.8769
guidance	false	0.7817999999999999
ect	false	0.6640999999999999
iv	false	0.5482
##########END##########
194
do not use ect routinely for people with moderate depression but consider it if their depression has not responded to multiple drug treatments and psychological treatment.
T4
T3
multiple drug treatments	false	1.3333
T2
psychological treatment	false	1.2263
T1
ect	false	0.6640999999999999
##########END##########
195
ect, consider a repeat trial of ect only after: reviewing the adequacy of the previous treatment course and considering all other options and discussing the risks and benefits with the person and/or, where appropriate, their advoc
T4
T3
T2
previous treatment	false	1.073
T1
review	true	0.5482
options	false	0.791
ect	false	0.6640999999999999
##########END##########
